Effects of low day 3 luteinizing hormone levels on in vitro fertilization treatment outcome

Gynecological Endocrinology

Volumn 14, Issue 5, 2000, Pages 321-326

  Noci, I ^a   Maggi, M ^a   Fuzzi, B ^a   Biagiotti, R ^a   Ricci, F ^a   Marchionni, M ^a  

^a Clinica Ginecologica e Ostetrica   (Italy)

Author keywords

Controlled Ovarian Hyperstimulation; In Vitro Fertilization; Luteinizing Hormone; Ovarian Reserve

Indexed keywords

BUSERELIN; GONADORELIN DERIVATIVE; LUTEINIZING HORMONE; UROFOLLITROPIN;

ADULT; ARTICLE; FEMALE; FERTILIZATION IN VITRO; HORMONE RESPONSE; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OVARY FOLLICLE CELL; OVARY HYPERSTIMULATION; PRIORITY JOURNAL;

EID: 0033678771     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513590009167700     Document Type: Article

References (27)

1. Steroids in the follicular fluid and the corpus luteum of the mare. A two cell type theory of ovarian steroid synthesis
2. Steroid formation by isolated and recombined ovarian granulosa and theca cells
3. Induction of follicular growth using recombinant human follicle stimulating hormone in two volunteer women with hypogonadotrophic hypogonadism
4. The role of pituitary gonadotropins in follicular stimulation and oocyte maturation in the human
5. Human urinary follicle stimulating hormone and human menopausal gonadotropin in induction of multiple follicle growth and ovulation
6. Comparison of the effects of follicle stimulating hormone and human menopausal gonadotropin on peripheral serum and follicular fluid hormones during ovarian stimulation
7. A randomised comparative study of purified follicle-stimulating hormone and human menopausal gonadotropin after pituitary desensitisation with buserelin for superovulation and in vitro fertilisation
8. Classification of anovulatory states
9. Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypergonadotropic hypogonadism patients
10. Ovarian response to purified FSH in infertile women with long-standing hypogonadotrophic hypogonadism
11. Hypogonadotropic disorders in men and women: Diagnosis and therapy with pulsatile gonadotropin releasing hormone
12. Pathophysiological relationships between the biological and immunological activities of luteinizing hormone
13. Low day 3 luteinizing hormone values are predictive of reduced response to ovarian stimulation
14. The routine use of gonadotropin-releasing hormone agonists for in vitro fertilization and gamete intrafallopian transfer: A meta-analysis of randomized controlled trials
15. Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome
16. Hormonal patterns, steroid receptors and morphological pictures of endometrium in hyperstimulated IVF cycles
17. The value of basal serum follicle stimulating hormone, luteinizing hormone and oestradiol concentrations following pituitary down-regulation in predicting ovarian response to stimulation with highly purified follicle stimulating hormone
18. Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone
19. Low day 3 luteinizing hormone values are predictive of reduced response to ovarian stimulation
20. Utilization of retrieved oocytes as an index of the efficiency of superovulation strategies for in vitro fertilization treatment
21. A successful assisted reproductive technology satellite program
22. Time to revolutionize ovarian stimulation
23. Minimal stimulation achieves pregnancy rates comparable to human menopausal gonadotropins in the treatment of infertility
24. Why delay the obvious need for milder forms of ovarian stimulation?
25. A randomized controlled trial of three low-dose gonadotrophin protocols for unexplained infertility
26. A prospective, randomized, double-blind clinical trial to study the efficacy and efficiency of a fixed dose of recombinant follicle stimulating hormone (Puregon) in women undergoing ovarian stimulation
27. Revival of the natural cycles in in vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): A pilot study with minimal stimulation